Sponsored by News
CMR Surgical announces significant update to robot
CMR Surgical (CMR) – the global surgical robotics business – has announced the launch of vLimeLite – an integrated fluorescence imaging system to visualise ICG (Indocyanine green), which will give surgeons enhanced visualisation, where indicated. Surgeons using Versius Plus – the latest version
of the Versius surgical robot – will be able to use vLimeLite to help perform visual assessment of the vessels, blood flow and related tissue perfusion, as well as biliary anatomy. vLimeLite is an integrated ICG system that allows visualisation of ICG with a choice of viewing mode for surgeons: overlay in full colour or greyscale. It also allows a choice of ICG colour: green or cyan. Supratim Bose, Chief Executive Officer of CMR
Surgical, commented: “With 3D HD visualisation, surgeons already have a fantastic view of their operating field at our Versius console. But now, with vLimeLite they can see beyond what the eye can see, allowing them to clearly visualise critical anatomy during their operations.” “This is the most significant update of Versius since it launched back in 2019. We have listened to the needs of surgeons, and I’m delighted that we have been able to give them what they want – a best-in-class ICG product that we know will make a real difference for their patients,” Bose added. Mark Slack, Chief Medical Officer and Co-
Founder of CMR Surgical, commented: “I think what is really special is the overlay mode option, which means Versius surgeons will be able to use our integrated ICG system, while continuing to view in full colour with the same video quality. vLimeLite truly allows surgeons to see what was once invisible to them.” Gloucestershire Royal Hospitals NHS Trust in the UK is the first hospital to install vLimeLite and its Upper GI team will be the first to start cases. Steve Hornby and Simon Higgs, Consultant
Upper GI Surgeons at Gloucestershire Hospitals NHS Foundation Trust, who will be the first to operate with vLimeLite, commented: “We’ve completed more than 200 cases with Versius at Gloucester Royal Hospital. As long-term partners of CMR, we were delighted to be the first to get our hands on its ICG system. We will utilise vLimeLite initially for our oesophagectomies and we can already tell what a difference vLimeLite is going to make.
“During the anastomosis of the stomach to the oesophagus, the visualisation and assessment of tissue perfusion will be much clearer, giving surgeons greater confidence in the health of the gastric conduit.” Professor Luigi Boni, Chief of the Department of
March 2024 I
www.clinicalservicesjournal.com 11
Minimally Invasive and General Surgery at Policlinico di Milano said: “I am pleased that vLimeLite has now launched. I have been working closely with CMR to help bring better ICG visualisation to surgical robotics. The launch of vLimeLite enables surgeons to use Versius for the vast majority of surgical procedures, offering the best surgical care to patients.” vLimeLite is launching initially in UK, Ireland and
Hong Kong. A global rollout of vLimeLite will follow, subject to local regulatory approvals and there will be further product launches as part of Versius Plus throughout 2024. The launch of vLimeLite follows CMR’s announcement that Q4 2023 was its
strongest quarter on record, with more installations of Versius around the world, and the highest number of procedures undertaken by surgeons.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68
